Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats

被引:217
作者
Masuda, O
Nakamura, Y
Takano, T
机构
[1] R. and D. Center, Calpis Food Industry Co., Ltd., Fuchinobe, Sagamihara
关键词
antihypertensive peptide; fermented milk; angiotensin I-converting enzyme; spontaneously hypertensive rats; intestinal absorption;
D O I
10.1093/jn/126.12.3063
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Absorption of inhibitory peptides to angiotensin I-converting enzyme, L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline, was studied in spontaneously hypertensive rats and normotensive Wistar-Kyoto rats after an oral administration of Calpis-(TM) sour milk, which contains these peptides. Six hours after the administration of Calpis(TM) sour milk or saline to spontaneously hypertensive rats or normotensive Wistar-Kyoto rats, the blood pressure was measured and rats were killed. Abdominal aorta, lung, kidney, heart and brain were excised, homogenized and solubilized by detergent treatments. Angiotensin I-converting enzyme activity in the solubilized fractions from the abdominal aorta was significantly lower in spontaneously hypertensive rats given the sour milk than in the rats given saline. L-Valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline were detected by HPLC in the heat-treated solubilized fraction from the abdominal aorta of spontaneously hypertensive rats given the sour milk. In contrast, the tripeptides were not detected in rats given saline, or in normotensive Wistar-Kyoto rats given the sour milk or saline. These data suggest that L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline in the Calpis(TM) sour milk are absorbed directly without being decomposed by digestive enzymes, reach the abdominal aorta, inhibit the angiotensin I-converting enzyme, and show antihypertensive effects in spontaneously hypertensive rats.
引用
收藏
页码:3063 / 3068
页数:6
相关论文
共 34 条
[1]  
Adibi S A, 1977, Ciba Found Symp, P265
[2]  
[Anonymous], 1982, PRINCIPLES PROCEDURE
[3]   DIFFERENTIAL-EFFECTS OF ORAL TRANDOLAPRIL AND ENALAPRIL ON RAT-TISSUE ANGIOTENSIN-CONVERTING ENZYME [J].
CHEVILLARD, C ;
BROWN, NL ;
MATHIEU, MN ;
LALIBERTE, F ;
WORCEL, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 147 (01) :23-28
[4]   EFFECT OF ACUTE ORAL-ADMINISTRATION OF CAPTOPRIL AND MK-421 ON VASCULAR ANGIOTENSIN CONVERTING ENZYME-ACTIVITY IN THE SPONTANEOUSLY HYPERTENSIVE RAT [J].
COHEN, ML ;
WILEY, KS ;
KURZ, KD .
LIFE SCIENCES, 1983, 32 (06) :565-569
[5]   SPECTROPHOTOMETRIC ASSAY AND PROPERTIES OF ANGIOTENSIN-CONVERTING ENZYME OF RABBIT LUNG [J].
CUSHMAN, DW ;
CHEUNG, HS .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (07) :1637-+
[6]  
DAS M, 1975, J BIOL CHEM, V250, P6762
[7]   ANGIOTENSIN-I CONVERTING ENZYME [J].
ERDOS, EG .
CIRCULATION RESEARCH, 1975, 36 (02) :247-255
[8]   ISO-RENIN OF EXTRARENAL ORIGIN - TISSUE ANGIOTENSINOGENASE SYSTEMS [J].
GANTEN, D ;
SCHELLING, P ;
VECSEI, P ;
GANTEN, U .
AMERICAN JOURNAL OF MEDICINE, 1976, 60 (06) :760-772
[9]  
GIASSON SD, 1981, J PHYSIOL PHARMACOL, V59, P528
[10]   PORTAL ABSORPTION OF SMALL PEPTIDES IN RATS UNDER UNRESTRAINED CONDITIONS [J].
HARA, H ;
FUNABIKI, R ;
IWATA, M ;
YAMAZAKI, KI .
JOURNAL OF NUTRITION, 1984, 114 (06) :1122-1129